II UPDATE ON OPTIC NERVE DEGENERATION
A European Network


17–18 March 2017, Barcelona Spain

PROGRAM 17 MARCH 2017




08:00–09:00

Accreditation

 

09:00–09:30

CONGRESS OPENING

 

Optic nerve in primary neurodegenerative disorders
Chairpersons: Philipp Albrecht & Piero Barboni

09:30–09:50

APOSTEL: consensus recommendations for reporting of quantitative optical coherence tomography study results
Philipp Albrecht

09:50–10:10

Visual afferent damage in patients with REM Behavior Disorder
Ana I Tercero-Uribe

10:10–10:40

New insights into Parkinson's disease and eye
Alexander U Brandt

10:40–11:10

The eye: a window to the brain also for Alzheimer's Disease?
Luis E Pablo

 

11:10–11:40

Coffee break

 

11:40–12:10

KEYNOTE lecture
Immune-mediated disorders involving retina and optic nerve
Francesc Graus

 

SYMPOSIUM BIOGEN
Neuroprotection in MS: Targeting inflammatory activity effectively from the onset
Elena H Martinez-Lapiscina & Pablo Villoslada

12:10–12:40

The complex relationship between neurodegeneration, demyelination and inflammation: influence in the clinical outcome
Pablo Villoslada

12:40–13:10

Targeting inflammation from the onset: evidences from studies focused on the damage through the visual afferent pathway
Elena H Martinez-Lapiscina

 

13:10–14:10

Lunch Break

 

Optic nerve in immune-mediated neurodegenerative disorders
Chairpersons: Elena H Martinez-Lapiscina & Giancarlo Comi

14:10–14:30

Visual assessment in clinical practice in MS and NMOSD
Bernardo Sanchez-Dalmau

14:30–14:50

Optic neuritis in NMOSD
Maria Sepúlveda

14:50–15:10

CROCTINO Study: towards clinical advances in NMOSD
Hanna Zimmermann

15:10–15:30

Role of demyelination in MS: VEP as surrogate outcome to measure myelin repair strategies in MS
Letizia Leocani

 

Patrocinado por Novartis

15:30–15:50

RNFL assessment in multiple sclerosis: update on current studies and longterm predictive value based on the fingolimod trial program
Diego G Silva, Medical Director, Novartis AG, Switzerland

 

ACUTE OPTIC NEURITIS AS A PARADIGM FOR PHASE II RCT IN MS AND NMOSD
Chairpersons: Bernardo Sanchez-Dalmau & Letizia Leocani

15:50–16:10

Natural history of acute optic neuritis
Jette Frederiksen

16:10–16:30

Remyelination and Neuroprotection strategy
Pablo Villoslada

16:30–16:50

Meta-analyses in AON trial: towards a standardization of outcomes
Elena H Martinez-Lapiscina

 

SYMPOSIUM OPKO HEALTH SPAIN
José Álvarez Sabín, Rafael Simó

17:00–17:30

Neuroprotective and neuroregenerative properties of citicoline: an opportunity for ocular neurodegenerative pathologies
José Álvarez Sabín, Rafael Simó

 

PRE–PROGRAM 18 MARCH 2017

Glaucoma
Chairpersons: Augusto Azuara-Blanco & Francesca Cordeiro

09:00–09:30

KEYNOTE lecture
Evaluating the effectiveness of novel interventions for glaucoma. Methodology and design of randomised controlled trials
Augusto Azuara-Blanco

09:30–09:50

The lamina cribrosa as the primary site of glaucoma damage
Gema Rebolleda

09:50–10:10

Neuroprotection in Glaucoma: Current strategies and future directions
Francesca Cordeiro

10:10–10:40

Surgery for Glaucoma
Maribel Canut

 

10:40–11:00

Coffee break

 

Hereditary Optic Nerve disorders
Chairperson: Valerio Carelli & Thomas Klopstock

11:00–11:20

Management of patients with suspicious of hereditary optic nerve disorders
Carmen Ayuso

11:20–11:35

Pediatric hereditary optic neuropathies
Marta Galdós

11:35–11:55

New frontiers on vascular supply in hereditary optic neuropathy
Piero Barboni

11:55–12:10

Inherited optic neuropathy: enlarging the genetic landscape
Valerio Carelli

12:10–12:30

Update on dominant optic atrophy
Marcela Votruba

 

SYMPOSIUM SANTHERA
Leber’s Hereditary Optic Neuropathy (LHON): What to do today in terms of diagnosis and patient management
Gema Rebolleda

12:30–12:45

Chairman introduction
Gema Rebolleda

12:45–13:00

Understanding of the disease and early diagnosis
Bernardo Sanchez-Dalmau

13:00–13:15

Patients Care: Raxone, the new treatment option for LHON´s patients
Thomas Klopstock

 

13:15–14:15

Lunch Break

 

Immune mediated optic neuropathies
Chairpersons: Bernardo Sánchez-Dalmau & Jérôme de Sèze

14:15–14:40

Immune-mediated optic neuropathies: RION and CRION
Jérôme de Sèze

14:40–14:55

Role of GQ1b R in optic nerve
Marianna Spatola

14:55–15:10

Role of GlyR in optic nerve
Eugenia Martinez Hernández

 

Innovation for retinal and optic nerve assessment
Chairpersons: Pablo Loza & Alexander U Brandt

15:10–15:30

New devices for retinal and optic nerve assessment
Brian Fernández

15:30–15:50

Optic properties of retinal structural imaging by optical coherence tomography
Delia DeBuc

15:50–16:10

New optic-based technologies to evaluate retinal damage
David Merino

16:10–16:30

New approaches for mfVEP signal analyses
Luis de Santiago Rodrigo

16:30–16:50

Modern tools to study neuroprotection in the adult rodent retina
Manuel Vidal-Sanz

 

16:50

Closing Remark

Invited Speakers

Albrecht, Philipp
Consultant Neurologist, Department of Neurology, University Hospital Düsseldorf, Düsseldorf, Germany
Álvarez Sabín, José
Barcelona, Spain
Ayuso, Carmen
Director of Biomedical Research Institute Fundación Jimenez Diaz (IIS-FJD, UAM), Chief of Clinical Genetics Department, University Hospital Fundación Jiménez Díaz, Madrid, Spain
Azuara-Blanco, Augusto
Professor of Ophthalmology, Queen's University, Belfast, UK
Barboni, Piero
Consultant Ophthalmologist, Scientific Institute San Raffaele, University of Milan, Italia
Brandt, Alexander U
Berlin, Germany
Canut, Maribel
Senior Eye Surgeon, Head Glaucoma department, Centro de Oftalmología Barraquer, Barcelona, Spain
Carelli, Valerio
Bologna, Italy
Comi, Giancarlo
Milan, Italy
Cordeiro, Francesca
Chair of Ophthalmology at Imperial College London. Head of “Glaucoma and Retinal Neurodegeneration Research Group" at UCL Institute of Ophthalmology. Director of the Clinical Trials Research Unit, Western Eye Hospital, Imperial College Healthcare NHS Trust in London. Chairman of ICORG. London, UK
DeBuc, Delia
Research Associate Professor, Department of Ophthalmology, University of Miami, Miller School of Medicine, Miami, FL, US
De Sèze, Jérôme
Head of Department of Neuroimmunology, Head of the clinical research center (CIC), Strasbourg Hospital
De Santiago Rodrigo, Luis
Biomedical Research Group (GIB), Universidad de Alcalá, Madrid, Spain
Fernández, Brian
Medical Science Liaison, Clinical Affairs Glaucoma/Neurology, Heidelberg Engineering, Franklin, MA, US
Frederiksen, Jette
Professor of Neurology, Senior Consultant, Department of Neurology, Rigshospitalet, Glostrup, Copenhagen, Denmark
Galdós, Marta
Médico Oftalmólogo y Doctora en Medicina, subespecialista en Estrabología, Oftalmología Pediátrica y Neuroftalmología, Hospital de Cruces, Bilbao, Spain
Graus, Francesc
Head of Neurology Section, Hospital Clínic, Barcelona, Spain
Leocani, Letizia
Associate Professor of Neurology, San Raffaele University, Milan, Italy
Loza, Pablo
Barcelona, Spain
Martinez-Hernández, Eugenia
Neurologist Hospital Clinic, Barcelona, Spain
Martinez-Lapiscina, Elena H
Neurologist Hospital Clínic, Barcelona, Spain
Merino, David
Research Fellow in the Superresolution Light Nanoscopy Facility, ICFO, Barcelona, Spain
Pablo, Luis E
Chairman, Ophthalmology and Optics, Head of Department, University Hospital Miguel Servet. Scientific deputy, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, Zaragoza, Spain
Rebolleda, Gema
Professor Ophthamology, Universidad de Alcalá, Madrid, Spain
Sanchez-Dalmau, Bernardo
Consultant in Neuro-Ophthalmology, Hospital Clínic, Barcelona, Spain
Sepulveda, Maria
Barcelona, Spain
Silva, Diego G
Medical Director, Novartis AG, Basel, Switzerland
Simó, Rafael
Barcelona, Spain
Spatola, Marianna
Neurologist & Research Associate, Institute of Biomedical Sciences August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Tercero-Uribe, Ana I
Barcelona, Spain
Vidal-Sanz, Manuel
Professor of Experimental Ophthalmology, Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria-Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain
Villoslada, Pablo
Adjunct Professor, Neurology Department, UCSF, San Francisco, CA, US. Senior Scientist, IDIBAPS, Barcelona, Spain
Votruba, Marcela
Professor of Ophthalmology & Head of School of School of Optometry & Vision Sciences, Cardiff University and University Hospital, Wales
Zimmermann, Hanna
Research associate, Neurodiagnostics Laboratory & Neuroimmunology Group, NeuroCure Clinical Research Center (NCRC), Charité – Universitätsmedizin Berlin, Germany

General Info

Organized By
Dr. Elena H Martinez-Lapiscina & Dr. Bernardo Sanchez-Dalmau ​on behalf of The ​Visual Pathway Lab​ part of ​Hospital Clinic of Barcelona & Institute of Biomedical Sciences August Pi i Sunyer



MISSION
EUPON inspires European multidisciplinary collaborations to further the knowledge in ophthalmological and neurological optic nerve pathologies.

VISION
To be a European reference and lead international efforts in diagnostic, therapeutic and research strategies involving optic nerve.

TARGET AUDIENCE
Opthalmologist, Neurologist, Engineers working in Biomedicine, Optometrists, Nurses



REGISTRATION FEES (VAT INCLUDED)
Ophthalmologists, Neurologists, Genetists
200€
Optometrist, Nurses
100€
Students in Medicine
(Ophthalmology - Neurology, Upon presentation of specialization certificate)
100€


VENUE
Paraninfo de la Facultad de Medicina de la UB
C/ Casanova 143, 08036 Barcelona



ACCREDITATION

Accredited by the “European Accreditation Council for Continuing Medical Education” (EACCME) with 10 European CME credits



ENDORSED BY

Sponsored by

DIAMOND

 

PLATINUM

 

GOLD



Organized by



SECRETARÍA TÉCNICA

Meetingpharma – A/A Fernando Ochoa
T. 934 703 513 – fochoa@meetingpharma.com



www.meetingpharmagroup.com